Related Experiment Video

Updated: Jun 11, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K

Polypills in the Management of Cardiovascular Risk-A Perspective

Erlon Oliveira de Abreu-Silva1,2, Martin Siepmann3, Timo Siepmann2,4

  • 1Hcor Research Institute, Hcor (IP-Hcor), Abílio Soares Street 250, São Paulo 04004-050, Brazil.

Journal of Clinical Medicine
|September 28, 2024
PubMed

Insights

Polypills, a combination of multiple drugs in one pill, can simplify treatment and improve patient adherence for managing cardiovascular disease risk factors. This strategy offers potential for better cardiovascular health outcomes globally.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Cardiovascular disease and its risk factors represent a significant global health challenge.
  • Inadequate control of cardiovascular risk factors is common, despite extensive evidence on therapeutic options.
  • Poor patient adherence and limited prescription of evidence-based therapies contribute to suboptimal cardiovascular risk management.

Purpose of the Study:

  • To review the current literature on the use of polypills in cardiovascular disease prevention.
  • To explore the potential of polypill therapy in simplifying pharmacotherapy and enhancing treatment adherence.
  • To discuss future challenges and opportunities associated with polypill implementation.

Main Methods:

  • Literature review of studies on polypill use in cardiovascular disease.
  • Analysis of factors influencing treatment adherence and therapy prescription.
  • Discussion of polypill design and its pharmacological implications.

Main Results:

  • Polypills, as fixed-dose combinations, are designed to simplify medication regimens.
  • The use of polypills has the potential to significantly improve patient adherence to treatment.
  • Evidence on polypill efficacy in primary and secondary cardiovascular disease prevention is under review.

Conclusions:

  • Polypills offer a promising strategy for simplifying pharmacotherapy and improving adherence in cardiovascular disease management.
  • Further research and implementation strategies are needed to address future challenges and maximize the potential of polypills.
  • Optimizing polypill use can contribute to better global control of cardiovascular risk factors.

Keywords:
LDL-cholesteroladherenceblood pressurecardiovascular diseasemortalitypolypill

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
483
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
3
Coronary Artery Disease IV: Medical Management01:26

Coronary Artery Disease IV: Medical Management

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
3